Chronic inflammation and lipid accumulation in the liver, driven by obesity, activate TGF-β signaling pathways, promoting hepatic fibrosis and metabolic dysregulation. Here, TGFB1 is linked to obesity due to melanocortin 4 receptor deficiency.